Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Petrolatum

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Petrolatum1

Active Sponsors

  • Universitas Indonesia1
  • National Health Research Institutes, Taiwan1
  • National Science and Technology Council, Taiwan1
  • National Taiwan University Hospital1

Top Investigators

Related Conditions

  • Skin Tag1
  • Seborrheic Keratosis1
  • Human Papillomavirus1
  • Soft Fibroma1
  • Hpv1

Activity Timeline